• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
RGEN

RGEN

Repligen Corporation

NASDAQHealthcareMedical - Instruments & SuppliesUS

USD121.73

+0.60 (+0.50%)

Rating:B-

Company Profile

CEO

Olivier Loeillot

IPO Date

1986-04-29

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Country

US

Market Metrics

Open

$119.40

Prev. Close

$121.13

Day Low

$117.59

Day High

$122.32

52W Low

$100.99

52W High

$175.77

Market Cap

$6.87B

Volume

0.65M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

44.3%

Avg Negative

3.8%

Avg Neutral

51.9%

News Feed

Why Repligen Stock Soared This Week

The Motley Fool·7/30/2021·↑ positive

Repligen (RGEN) Beats on Q2 Earnings & Sales, Ups 2021 View

Zacks Investment Research·7/28/2021·↑ positive

Repligen Corp, Inc. (RGEN) CEO Anthony Hunt on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·7/27/2021·↓ negative

Recap: Repligen Q2 Earnings

Benzinga·7/27/2021·↑ positive

Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

GlobeNewsWire·7/27/2021·↓ negative

Earnings Outlook For Repligen

Benzinga·7/26/2021·↓ negative

Repligen to Report Second Quarter 2021 Financial Results

GlobeNewsWire·7/13/2021·↓ negative

Repligen To Buy Polymem For An Undisclosed Sum

Benzinga·6/22/2021·↑ positive

Repligen Corporation Announces Agreement to Acquire Polymem S.A.

GlobeNewsWire·6/22/2021·↑ positive

Repligen Corporation to Present at Upcoming Investor Conferences

GlobeNewsWire·5/25/2021·↑ positive